Web www.globalrph.com
Home Back *Drug Tables Disclaimer IV Dilutions *Health topics* Professional Resource 
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

GENTAMICIN
Usual Diluents
NS,  D5W
Standard Dilutions   [Amount of drug]  [Infusion volume]  [Infusion rate]
[0 to 40 mg] [50 ml] [30 min]
[>40mg] [100 ml] [30 min]
Stability / Miscellaneous
EXP: 1 DAY (RT) / 4 DAYS (REF)

Increased Vd: CHF, peritonitis, ascites, acute burn, hypo-albuminemia, immediate post partum. 

Kel (for gent/tobra/amikacin): (crcl) (0.003) + 0.01 

Vd (for gent/tobra/amikacin): 0.3 L/kg ibw or adjusted body if >30% ibw. 

Adjusted body wt: (Actual body wt - ibw) (0.4) + ibw. 

Dose by levels (target trough): Gent/tobra: < 2 mcg/ml (<3 HD). Amikacin: < 8 mcg/ml (<10 HD). Estimation of dosing interval: Gent/Tobra/Amik: 3 x T1/2 Vanco: 2 x T1/2 (Note: may also solve for (T=dosing interval) using the Cmin equation). 

T= [ln (Cmax/Cmin) / Kel] + ti

Usual target trough (conventional dosing): Gent/Tobra: 0.5 to 1 mcg/ml // Amikacin: 4-8 mcg/ml. 

Monitoring: Scr qod or qd if unstable. Follow clinical response: monitor WBC, Tmax, C&S, I&O's. Obtain levels 30 minutes before and after a 30 min infusion.
 


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.